Arkolith/Insider Trading/BRTX/Form 4

Silva Francisco

VP of Research and Development, DirectorBioRestorative Therapies, Inc. (BRTX) · full profile →Form 4 · filed Apr 10, 2024
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 9, 2024Buy(P)7K$1.25$8K156K
Apr 8, 2024Buy(P)1K$1.17$1K149K
Apr 8, 2024Buy(P)476$1.13$538148K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001021771-24-000091) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML